Pathological tendon histology in early and chronic human patellar tendinopathy

The present pilot study investigated the extent of histological tissue changes in both chronic tendinopathy and in individuals that display early clinical signs of tendinopathy. The study included 8 individuals of whom 3 were healthy without any tendon symptoms, 2 had early symptoms (1–2 months), an...

Popoln opis

Bibliografske podrobnosti
Main Authors: Malmgaard-Clausen, NM, Kjaer, M, Dakin, SG
Format: Journal article
Jezik:English
Izdano: Hindawi 2021
_version_ 1826313615061286912
author Malmgaard-Clausen, NM
Kjaer, M
Dakin, SG
author_facet Malmgaard-Clausen, NM
Kjaer, M
Dakin, SG
author_sort Malmgaard-Clausen, NM
collection OXFORD
description The present pilot study investigated the extent of histological tissue changes in both chronic tendinopathy and in individuals that display early clinical signs of tendinopathy. The study included 8 individuals of whom 3 were healthy without any tendon symptoms, 2 had early symptoms (1–2 months), and 3 had chronic symptoms (>3 months) from their patellar tendons. Percutaneous needle biopsy samples were obtained from the affected tendon tissue region. Biopsy samples were stained with Haematoxylin & Eosin, and multiplex immunofluorescence staining was performed for markers of inflammation and resolution. Both early and chronic stage patellar tendon biopsy samples from this small patient cohort exhibited expansion of the interfascicular matrix (IFM) and endotenon regions together with increased cellularity and vascularity. These histological observations were moderate in early tendinopathy, whereas they were more pronounced and associated with marked disruption of tissue architecture in chronic tendinopathy. Early stage tendinopathic patellar tendons expressed markers associated with an activated phenotype of fibroblasts (CD90, CD34), macrophages (S100A8), and endothelial cells (ICAM1, VCAM1). These tissues also expressed enzymes implicated in inflammation (PTGS2, 15PGDH) and resolution (ALOX12) and the proresolving receptor ERV1. Immunopositive staining for these markers was predominantly located in the IFM regions. These preliminary findings suggest that mild to moderate structural histological changes including expansion of IFM and endotenon regions are pathological features of early tendinopathy, and support inflammatory and resolving processes are active in early-stage disease. Further investigation of the cellular and molecular basis of early-stage tendinopathy is required to inform therapeutic strategies that prevent the development of irreversible chronic tendon disease.
first_indexed 2024-03-07T07:35:21Z
format Journal article
id oxford-uuid:b9842673-390b-412d-bdaa-bc6da9c71095
institution University of Oxford
language English
last_indexed 2024-09-25T04:15:59Z
publishDate 2021
publisher Hindawi
record_format dspace
spelling oxford-uuid:b9842673-390b-412d-bdaa-bc6da9c710952024-07-20T14:36:57ZPathological tendon histology in early and chronic human patellar tendinopathyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b9842673-390b-412d-bdaa-bc6da9c71095EnglishSymplectic Elements Hindawi2021Malmgaard-Clausen, NMKjaer, MDakin, SGThe present pilot study investigated the extent of histological tissue changes in both chronic tendinopathy and in individuals that display early clinical signs of tendinopathy. The study included 8 individuals of whom 3 were healthy without any tendon symptoms, 2 had early symptoms (1–2 months), and 3 had chronic symptoms (>3 months) from their patellar tendons. Percutaneous needle biopsy samples were obtained from the affected tendon tissue region. Biopsy samples were stained with Haematoxylin & Eosin, and multiplex immunofluorescence staining was performed for markers of inflammation and resolution. Both early and chronic stage patellar tendon biopsy samples from this small patient cohort exhibited expansion of the interfascicular matrix (IFM) and endotenon regions together with increased cellularity and vascularity. These histological observations were moderate in early tendinopathy, whereas they were more pronounced and associated with marked disruption of tissue architecture in chronic tendinopathy. Early stage tendinopathic patellar tendons expressed markers associated with an activated phenotype of fibroblasts (CD90, CD34), macrophages (S100A8), and endothelial cells (ICAM1, VCAM1). These tissues also expressed enzymes implicated in inflammation (PTGS2, 15PGDH) and resolution (ALOX12) and the proresolving receptor ERV1. Immunopositive staining for these markers was predominantly located in the IFM regions. These preliminary findings suggest that mild to moderate structural histological changes including expansion of IFM and endotenon regions are pathological features of early tendinopathy, and support inflammatory and resolving processes are active in early-stage disease. Further investigation of the cellular and molecular basis of early-stage tendinopathy is required to inform therapeutic strategies that prevent the development of irreversible chronic tendon disease.
spellingShingle Malmgaard-Clausen, NM
Kjaer, M
Dakin, SG
Pathological tendon histology in early and chronic human patellar tendinopathy
title Pathological tendon histology in early and chronic human patellar tendinopathy
title_full Pathological tendon histology in early and chronic human patellar tendinopathy
title_fullStr Pathological tendon histology in early and chronic human patellar tendinopathy
title_full_unstemmed Pathological tendon histology in early and chronic human patellar tendinopathy
title_short Pathological tendon histology in early and chronic human patellar tendinopathy
title_sort pathological tendon histology in early and chronic human patellar tendinopathy
work_keys_str_mv AT malmgaardclausennm pathologicaltendonhistologyinearlyandchronichumanpatellartendinopathy
AT kjaerm pathologicaltendonhistologyinearlyandchronichumanpatellartendinopathy
AT dakinsg pathologicaltendonhistologyinearlyandchronichumanpatellartendinopathy